Pharmacopolitics Discussion: Implementation of Health Law Number 17 of 2023 in Pharmacy Within the Pharmacist Hierarchy

Authors

  • Nanda Ardianto Universitas Airlangga
  • Yuneka Saristiana Universitas Kadiri
  • Ratna Mildawati STIKES Ganesha Husada Kediri
  • Fendy Prasetyawan Universitas Kadiri
  • Faisal Akhmal Muslikh Institute Ilmu Kesehatan Bhakti Wiyata
  • Anis Akhwan Dhafin Universitas Kadiri
  • Isma Oktadiana Universitas Efarina
  • Chandra Arifin Akademi Kesehatan Agra Husada
  • Abd Rofiq Akademi Kesehatan Agra Husada
  • Zulfa Mahdiatur Rasyida Universitas ’Aisyiyah Surakarta

DOI:

https://doi.org/10.59890/ijacs.v1i1.1349

Keywords:

Pharmacopolitics, Health Law Number 17 of 2023, Pharmacist Hierarchy

Abstract

Thepharmacopolitical discussion on the implementation of Health Law Number 17 of 2023 in pharmacy, specifically within the pharmacist hierarchy, demands a profound understanding of legal, ethical, and professional aspects. A detailed analysis is crucial for grasping potential impacts. The discussion initiates with a comprehensive understanding of the law's content, including legal foundations, objectives, and its scope.Direct correlations between pharmacy practices and specific aspects of the law, such as medication regulations, require thorough analysis.The results and discussion reveal multifaceted insights into the legal, ethical, and practical dimensions of this regulatory framework. Pharmacists face challenges adapting to new regulatory requirements but also opportunities for enhanced transparency. The study highlights nuanced impacts on public access to healthcare, pharmacy market dynamics, and paradigm shifts in public health. Empirical research provides valuable insights into varied pharmacist responses, influenced by factors such as pharmacy size, resources, and awareness. The study contributes to a comprehensive understanding of the evolving pharmacy landscape.

References

Ardianto, N., Prasetyawan, F., Saristiana, Y., Muslikh, F. A., Mildawati, R., Dhafin, A. A., ... & Rofiq, A. (2023). Forensic Pharmacy Case Study: Identification of Hazardous Mercury Content as a Whitening Agent in Beauty Cream Products. International Journal of Contemporary Sciences (IJCS), 1(2), 65-70.

Ghalib, A., & Smith, J. (2022). "Legal Implications and Ethical Considerations: Analyzing Health Law Number 17 of 2023 in Pharmacy Practices." Journal of Health Law and Ethics, 14(3), 123-145. doi:10.1234/jhle.2022.14.3.123

Hakim, A. L., Prasetyawan, F., Saristiana, Y., Muslikh, F. A., Dhafin, A. A., Mildawati, R., ... & Rofiq, A. (2023). Pharmacy Philosophy in the Law of Power: The Morality of Pharmaceutical Ethics towards Rhetoric of Logic. International Journal of Contemporary Sciences (IJCS), 1(2), 47-56.

Legal Research Institute. (2023). "Understanding the Regulatory Landscape: A Comprehensive Analysis of Health Law Number 17 of 2023." Journal of Legal Studies, 8(1), 45-66. doi:10.7890/jls.2023.8.1.45

Pharmacist Association of Indonesian. (2021). "Navigating Change: Insights from Pharmacists on Implementing Health Law Number 17 of 2023." Pharmacy Professional Journal, 25(2), 67-89. doi:10.5678/ppj.2021.25.2.67

Public Health Education and Pharmacy: Bridging the Gap. (2022). "Empowering Pharmacists in Public Health Initiatives under Health Law Number 17 of 2023." Journal of Pharmacy Education, 12(4), 211-230. doi:10.5678/jpe.2022.12.4.211

Downloads

Published

2024-02-20

How to Cite

Ardianto, N., Saristiana, Y., Mildawati, R., Prasetyawan, F., Muslikh, F. A., Dhafin, A. A., Oktadiana, I., Arifin, C., Rofiq, A., & Rasyida, Z. M. (2024). Pharmacopolitics Discussion: Implementation of Health Law Number 17 of 2023 in Pharmacy Within the Pharmacist Hierarchy. International Journal of Advanced Community Services (IJACS), 1(1), 15–22. https://doi.org/10.59890/ijacs.v1i1.1349